openPR Logo
Press release

Food Allergy Pipeline Drugs and Companies Insight Report (2023): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

02-01-2023 12:55 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Food Allergy Pipeline Drugs and Companies Insight Report

Food Allergy pipeline constitutes 30+ key companies continuously working towards developing 35+ Food Allergy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

Food Allergy Overview
An immune system reaction known as a food allergy happens quickly after consuming a particular meal. A very small amount of the food that causes allergies can cause signs and symptoms like stomach issues, rashes, or enlarged airways. Some people may experience severe symptoms from a food allergy, including the potentially fatal anaphylactic reaction.

"Food Allergy Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Food Allergy Market.

The Food Allergy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Food Allergy Pipeline Report: https://www.delveinsight.com/report-store/food-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

• Companies across the globe are diligently working toward developing novel Food Allergy treatment therapies with a considerable amount of success over the years. Food Allergy Key players such as - Intrommune Therapeutics, Xencor, Vedanta Bioscience, Alladapt Immunotherapeutics, Aravax, Regeneron, DBV Technologies, Novartis AG, Camallergy, Genentech, and others, are developing therapies for the Food Allergy treatment
• Food Allergy Emerging therapies such as - INT301, AIMab7195, VE416, ADP101, PVX-108, Dupilumab, DBV 135, Ligelizumab, CA002, Omalizumab, and others are expected to have a significant impact on the Food Allergy market in the coming years.
• In November 2022, From the 2022 ACAAI meeting in Louisville, KY, Medpage reported on omalizumab (Xolair) which is proving to be an effective therapy for patients with multiple food allergies according to an ongoing phase 3 study named OUtMATCH
• US FDA has granted Breakthrough Therapy Designation for Xolair (omalizumab) for the prevention of severe allergic reactions following accidental exposure to 1 or more foods in patients with allergies

Food Allergy Pipeline Therapeutics Assessment
• Food Allergy Assessment by Product Type
• Food Allergy By Stage and Product Type
• Food Allergy Assessment by Route of Administration
• Food Allergy By Stage and Route of Administration
• Food Allergy Assessment by Molecule Type
• Food Allergy by Stage and Molecule Type

DelveInsight's Food Allergy Report covers around 35+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Emerging Food Allergy Drugs Under Different Phases of Clinical Development Include:
• INT301: Intrommune Therapeutics
• AIMab7195: Xencor
• VE416: Vedanta Bioscience
• ADP101: Alladapt Immunotherapeutics
• PVX-108: Aravax
• Dupilumab: Regeneron
• DBV 135: DBV Technologies
• Ligelizumab: Novartis AG
• CA002: Camallergy
• Omalizumab: Genentech

Get a Free Sample PDF Report to know more about Food Allergy Pipeline Assessment- https://www.delveinsight.com/sample-request/food-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Food Allergy Pipeline Analysis:
The Food Allergy pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the Food Allergy treatment with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Food Allergy Treatment.
• Food Allergy key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Food Allergy Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Food Allergy market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Further Food Allergy product details are provided in the report. Download the Food Allergy pipeline report to learn more about the emerging Food Allergy therapies at:
https://www.delveinsight.com/sample-request/food-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Food Allergy Pipeline Market Drivers
• Increasing prevalence of food allergies
• Growth in commercial and scientific activities for research and development

Food Allergy Pipeline Market Barriers
• Lack of Public awareness
• Accurate diagnosis of food allergies is critical

Scope of Food Allergy Pipeline Drug Insight
• Coverage: Global
• Key Food Allergy Companies: , and others
• Key Food Allergy Therapies: INT301, AIMab7195, VE416, ADP101, PVX-108, Dupilumab, DBV 135, Ligelizumab, CA002, Omalizumab, and others
• Food Allergy Therapeutic Assessment: Food Allergy current marketed and Food Allergy emerging therapies
• Food Allergy Market Dynamics: Food Allergy market drivers and Food Allergy market barriers

Request for Sample PDF Report for Food Allergy Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/food-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Food Allergy Report Introduction
2 Food Allergy Executive Summary
3 Food Allergy Overview
4 Food Allergy- Analytical Perspective In-depth Commercial Assessment
5 Food Allergy Pipeline Therapeutics
6 Food Allergy Late Stage Products (Phase II/III)
7 Food Allergy Mid Stage Products (Phase II)
8 Food Allergy Early Stage Products (Phase I)
9 Food Allergy Preclinical Stage Products
10 Food Allergy Therapeutics Assessment
11 Food Allergy Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Food Allergy Key Companies
14 Food Allergy Key Products
15 Food Allergy Unmet Needs
16 Food Allergy Market Drivers and Barriers
17 Food Allergy Future Perspectives and Conclusion
18 Food Allergy Analyst Views
19 Appendix
20 About DelveInsight

Download Sample PDF Report to know more about Food Allergy drugs and therapies- https://www.delveinsight.com/sample-request/food-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Related Reports:

Food Allergy Market https://www.delveinsight.com/report-store/food-allergy-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Food Allergy-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Food Allergy Epidemiology https://www.delveinsight.com/report-store/food-allergy-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Food Allergy Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:

Related Reports By DelveInsight -

Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Hypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Lung Fibrosis Market https://www.delveinsight.com/report-store/lung-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Lung Fibrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lung Fibrosis, historical and forecasted epidemiology as well as the Lung Fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Anterior Uveitis Market https://www.delveinsight.com/report-store/anterior-uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

22q11.2 deletion syndrome Market https://www.delveinsight.com/report-store/22q112-deletion-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "22q11.2 Deletion Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the 22q11.2 Deletion Syndrome, historical and forecasted epidemiology as well as the 22q11.2 Deletion Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

X-Linked Retinitis Pigmentosa (XLRP) Market https://www.delveinsight.com/report-store/x-linked-retinitis-pigmentosa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "X-Linked Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the X-Linked Retinitis Pigmentosa (XLRP), historical and forecasted epidemiology as well as the X-Linked Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Recent Blog's By DelveInsight:

• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Contact Us:

Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Food Allergy Pipeline Drugs and Companies Insight Report (2023): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here

News-ID: 2908675 • Views:

More Releases from DelveInsight Business Research

Waldenstrom Macroglobulinemia Market Analysis 2034 - Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, Companies by DelveInsight
Waldenstrom Macroglobulinemia Market Analysis 2034 - Competitive Landscape, Clin …
Waldenström macroglobulinemia (WM) is a rare, slow-developing non-Hodgkin lymphoma characterized by abnormal B-cell growth in the bone marrow and excessive production of IgM protein. In 2023, around 3,190 new cases were reported across the 7MM, with the US contributing about 40%. The disease is more common in males, and nearly half of cases occur in individuals over 65 due to genetic and age-related factors, including the MYD88 L265P mutation found
Wilson's Disease Market Analysis 2034 - Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, Companies by DelveInsight
Wilson's Disease Market Analysis 2034 - Competitive Landscape, Clinical Trials, …
DelveInsight reports that approximately 8,000 diagnosed prevalent cases of Wilson's Disease were recorded in the 7MM in 2023, with numbers projected to rise through 2034. The United States leads the market with a 2023 valuation of about USD 126 million, expected to grow at a CAGR of 13%. Current treatment mainly involves chelating agents and zinc salts, with chelating agents dominating the U.S. market at around USD 123 million. Recent
Biktarvy Market and Sales Forecast: Strong Global Adoption, Expanding Indications, and Continued Leadership in HIV Therapy | DelveInsight
Biktarvy Market and Sales Forecast: Strong Global Adoption, Expanding Indication …
DelveInsight, a leading business intelligence and market research firm, announced the publication of its latest report, "Biktarvy Market Insights, Sales Forecast, and Competitive Landscape - 2034." The report provides an in-depth commercial, clinical, and strategic outlook on Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide), reinforcing its continued leadership as one of the most widely prescribed HIV therapies worldwide. As global healthcare systems increasingly adopt simplified antiretroviral regimens to improve adherence and long-term viral suppression, Biktarvy
Global Biologics Contract Manufacturing Market to reach USD 47,494.63 million at a CAGR of 9.39% by 2032, Evaluates DelveInsight
Global Biologics Contract Manufacturing Market to reach USD 47,494.63 million at …
According to DelveInsight's analysis, The increasing incidence of chronic conditions such as cancer, diabetes, and autoimmune diseases is driving the demand for biologic therapies, prompting pharmaceutical companies to outsource large-scale production to contract manufacturers. Additionally, the expanding pipeline of biologics-including monoclonal antibodies, vaccines, and biosimilars-necessitates adaptable manufacturing solutions to address rising market demand efficiently. Moreover, advancements in biotechnology and biomedical techniques, such as recombinant DNA technology and enhanced expression systems,

All 5 Releases


More Releases for Food

Food Ultrasound Market Food Ultrasound Market
According to a new report by InsightAce Analytic, the "Food Ultrasound Market" in terms of revenue was estimated to be worth $156.24 Mn in 2023 and is poised to reach $310.45 Mn by 2031, growing at a CAGR of 9.14% from 2024 to 2031. Request For Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1551 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global Food Ultrasound Market are: • Food Safety and Quality Assurance. • Increasing Consumer
Prepared Food Market To Witness Huge Growth By 2028 | HSL Food, HelloFresh, Syne …
The Latest survey report on Prepared Food Market sheds lights on changing dynamics in Food & Beverages Sector and elaborates market size and growth pattern of each of Prepared Food segments. As the shift to value continues, the producers are tackling challenges to personalized nutrition and match taste profiles. A wide list of manufactuerers were considered in the survey; to include mix bag of leaders and emerging manufacturers for company
Cookies for Food Services Market Is Booming Worldwide | Finsbury Food Group, Mon …
Cookies for Food Services Market: The extensive research on Cookies for Food Services Market, by Qurate Research is a clear representation on all the essential factors that are expected to drive the market considerably. Thorough study on Cookies for Food Services Market helps the buyers of the report, customers, the stakeholders, business owners, and stockholders to understand the market in detail. The updated research report comprises key information on the
Global Sports Food Market By Type (Protein Sports Food, Energy Sports Food, Misc …
The Global Sports Food Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Sports Food Market report aims to provide an overview of Sports Food Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Sports Food Market Economy
Global Packed Food Market 2018 Analysis By Key Players – JBS Food, Kraft Food, …
Summary WiseGuyReports.com adds “Packed Food Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database. This report provides in depth study of “Packed Food Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Packed Food Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as
Pet Food Market (By Food Type, By Animal Type, By Region, By Country) of Food Ty …
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global pet food market on the basis of Food Type (Dry, Wet, Snacks, Mixers); Animal Type (Dog Food, Cat Food, Fish Food, Others), By Region (North America, Europe, APAC, ROW) and By Country (U.S.A, Canada, UK, Germany, Japan, India, China, France). Global Pet Food